Nature Cell acquired a stem cell manufacturing facility and is seeking BLA filing for its stem cell therapy.

The entities involved

• FDA →
  • PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.21:51
  • The FDA (Q11200607) and the Food Safety and Standards Authority of India (Q5465383) are involved in a new development regarding the governance of inspections.20:44
• Baltimore →

  city in Maryland, United States

  • A person traveled from Pikesville to Israel, having previously worked in Baltimore, amidst the ongoing Gaza War.21:53
  • Case emerged from Baltimore, Maryland jurisdiction concerning immigration issues between US states and Mexico.19:43

Related events

• FDA accepts a BLA for biosimilar review and extends its review process to Health Canada.Oct 13
• A network focused on cell and gene therapies is expanding to include sites in Northern California, involving the CA Institute for Regenerative Medicine and the FDA.Sep 25
• FDA provided guidance for HCW Biologics' IND application.Oct 9